Olukotun Adeoye Y insider trades
Olukotun Adeoye Y has filed 18 Form 4s with the SEC that we hold, for Arrowhead Pharmaceuticals, INC. (ARWR) (Director) and Tonix Pharmaceuticals Holding Corp. (TNXP) (Director). Across all of them we count 0 purchases worth $0 and 12 sales worth $1.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($850.5K). The largest single trade was a sale of 6,083 shares of Arrowhead Pharmaceuticals, INC. worth $413.9K, dated 2025-12-19. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-14 and the latest 2026-08-20.
Arrowhead Pharmaceuticals, INC. (ARWR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-13 | S, sale reported on Form 4 | 2,250 | $143.5K | 2021-09-14 |
| 2021-09-13 | S, sale reported on Form 4 | 2,750 | $175.3K | 2021-09-14 |
| 2022-01-03 | S, sale reported on Form 4 | 1,916 | $124.6K | 2022-01-04 |
| 2022-01-03 | S, sale reported on Form 4 | 244 | $16.2K | 2022-01-04 |
| 2022-01-03 | S, sale reported on Form 4 | 1,890 | $121.5K | 2022-01-04 |
| 2023-03-03 | S, sale reported on Form 4 | 11,350 | $370.6K | 2023-03-06 |
| 2024-12-27 | S, sale reported on Form 4 | 2,850 | $57.0K | 2024-12-30 |
| 2025-01-23 | S, sale reported on Form 4 | 959 | $20.1K | 2025-01-27 |
| 2025-12-19 | S, sale reported on Form 4 | 3,090 | $206.1K | 2025-12-23 |
| 2025-12-19 | S, sale reported on Form 4 | 6,083 | $413.9K | 2025-12-23 |
| 2025-12-19 | S, sale reported on Form 4 | 827 | $56.6K | 2025-12-23 |
| 2026-08-18 | S, sale reported on Form 4 | 2,000 | $173.9K | 2026-08-20 |
Tonix Pharmaceuticals Holding Corp. (TNXP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1242615) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms